Literature DB >> 28815076

Definitive chemoradiotherapy.

Michael Stahl1, Wilfried Budach2.   

Abstract

Definitive chemoradiotherapy (dCRT) is reflecting a treatment standard in oesophageal cancer. For irresectable localised tumours and for inoperable patients, dCRT can change the treatment intent from palliative to curative. In patients with squamous cell carcinoma (SCC), in particular in those of cervical location, dCRT is a proper alternative for treatment that may include radical surgery. Patients with localised locoregional recurrence after primary surgery can survive for long-term after salvage CRT.

Entities:  

Keywords:  Definitive chemoradiotherapy (dCRT); oesophageal cancer

Year:  2017        PMID： 28815076      PMCID： PMC5538992          DOI： 10.21037/jtd.2017.05.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  35 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer.

Authors:  Wen Yu; Xu-Wei Cai; Qi Liu; Zheng-Fei Zhu; Wen Feng; Qin Zhang; Ying-Jian Zhang; Zhi-Feng Yao; Xiao-Long Fu
Journal:  Radiother Oncol       Date:  2015-01-10       Impact factor: 6.280

3.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

4.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.

Authors:  Justin K Smit; Christina T Muijs; Johannes G M Burgerhof; Gabriel Paardekooper; Paul R Timmer; Karin Muller; Dankert Woutersen; Véronique E Mul; Jannet C Beukema; Geke A P Hospers; Boukje A C van Dijk; Johannes A Langendijk; John Th M Plukker
Journal:  Ann Surg Oncol       Date:  2012-12-29       Impact factor: 5.344

6.  Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

Authors:  Thierry Conroy; Marie-Pierre Galais; Jean-Luc Raoul; Olivier Bouché; Sophie Gourgou-Bourgade; Jean-Yves Douillard; Pierre-Luc Etienne; Valérie Boige; Isabelle Martel-Lafay; Pierre Michel; Carmen Llacer-Moscardo; Eric François; Gilles Créhange; Meher Ben Abdelghani; Beata Juzyna; Laurent Bedenne; Antoine Adenis
Journal:  Lancet Oncol       Date:  2014-02-18       Impact factor: 41.316

7.  Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

Authors:  Karin Ribi; Dieter Koeberle; Jan C Schuller; Hanspeter Honegger; Arnaud Roth; Viviane Hess; Peter Moosmann; Roger von Moos; Markus Borner; Norbert Lombriser; Bernhard Pestalozzi; Thomas Ruhstaller
Journal:  Support Care Cancer       Date:  2009-02-07       Impact factor: 3.603

8.  Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.

Authors:  Jian Zhang; Feng Peng; Na Li; Yongmei Liu; Yong Xu; Lin Zhou; Jin Wang; Jiang Zhu; Meijuan Huang; Youling Gong
Journal:  Radiat Oncol       Date:  2012-06-19       Impact factor: 3.481

9.  Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.

Authors:  Hui-Shan Chen; Wei-Heng Hung; Jiunn-Liang Ko; Po-Kuei Hsu; Chia-Chuan Liu; Shiao-Chi Wu; Ching-Hsiung Lin; Bing-Yen Wang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.

Authors:  Thomas Crosby; Christopher N Hurt; Stephen Falk; Simon Gollins; Somnath Mukherjee; John Staffurth; Ruby Ray; Nadim Bashir; John A Bridgewater; J Ian Geh; David Cunningham; Jane Blazeby; Rajarshi Roy; Tim Maughan; Gareth Griffiths
Journal:  Lancet Oncol       Date:  2013-04-25       Impact factor: 41.316
View more
  8 in total

Review 1.  Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population.

Authors:  Dara Bracken-Clarke; Abdul Rehman Farooq; Anne M Horgan
Journal:  Curr Oncol Rep       Date:  2018-11-13       Impact factor: 5.075

2.  Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review.

Authors:  Elham Rahimy; Amanda Koong; Diego Toesca; Maya N White; Neil Panjwani; George Fisher; Daniel Chang; Erqi Pollom
Journal:  Adv Radiat Oncol       Date:  2020-05-21

Review 3.  Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy.

Authors:  Xiu-Yong Liao; Chao-Yuan Liu; Jian-Feng He; Li-Shu Wang; Tao Zhang
Journal:  Oncol Lett       Date:  2019-09-19       Impact factor: 2.967

4.  Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.

Authors:  Z Faiz; M van Putten; R H A Verhoeven; J W van Sandick; G A P Nieuwenhuijzen; M J C van der Sangen; V E P P Lemmens; B P L Wijnhoven; J T M Plukker
Journal:  Ann Surg Oncol       Date:  2019-02-04       Impact factor: 5.344

5.  Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.

Authors:  Sornjarod Oonsiri; Sarin Kitpanit; Danita Kannarunimit; Chakkapong Chakkabat; Chawalit Lertbutsayanukul; Anussara Prayongrat
Journal:  Phys Imaging Radiat Oncol       Date:  2022-04-28

6.  Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.

Authors:  Franziska Walter; David Böckle; Nina-Sophie Schmidt-Hegemann; Rebecca Köpple; Sabine Gerum; Stefan Boeck; Martin Angele; Claus Belka; Falk Roeder
Journal:  Radiat Oncol       Date:  2018-05-16       Impact factor: 3.481

7.  Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy.

Authors:  Chia-Hsin Lin; Tsung-Min Hung; Yu-Chuan Chang; Chia-Hsun Hsieh; Ming-Chieh Shih; Shih-Ming Huang; Chan-Keng Yang; Ching-Fu Chang; Sheng-Chieh Chan; Wing-Keen Yap
Journal:  Cancers (Basel)       Date:  2020-03-06       Impact factor: 6.639

Review 8.  Harnessing DNA Replication Stress for Novel Cancer Therapy.

Authors:  Huanbo Zhu; Umang Swami; Ranjan Preet; Jun Zhang
Journal:  Genes (Basel)       Date:  2020-08-25       Impact factor: 4.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.